Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drug development research

Showing results (321-330 of 1,376) with videos related to

Pageof 138
Sort By:
Drug Development Research|January 21, 2020
Development and characterization of oxaceprol-loaded poly-lactide-co-glycolide nanoparticles for the treatment of osteoarthritisEmine Alarçin, Çağlar Demirbağ, Seher Karsli-Ceppioglu, et al.
Drug Development Research|March 29, 2020
Oridonin ameliorates carbon tetrachloride-induced liver fibrosis in mice through inhibition of the NLRP3 inflammasomeDong Liu, Hailong Qin, Bixian Yang, et al.
Drug Development Research|September 15, 2020
Osteoarthritis: Prognosis and emerging therapeutic approach for disease managementAmresh Kumar, Partha Palit, Sabu Thomas, et al.
Drug Development Research|July 14, 2021
Targeting TRAF3IP2 alleviates high glucose-induced cardiomyocyte inflammation and apoptosisJing Wei, Tao Yan, Yuanhong Liang
Drug Development Research|October 3, 2020
Evaluation of hyaluronic acid nanoparticle embedded chitosan-gelatin hydrogels for antibiotic releaseBengi Özkahraman, Emel Tamahkar, Neslihan İdil, et al.
Drug Development Research|December 5, 2019
New 3-unsubstituted isoxazolones as potent human neutrophil elastase inhibitors: Synthesis and molecular dynamic simulationMaria Paola Giovannoni, Letizia Crocetti, Niccolò Cantini, et al.
Drug Development Research|July 8, 2022
Engineering of A<sub>3</sub> Adenosine and P2Y Nucleotide Receptors and Their LigandsKenneth A Jacobson, Hak Sung Kim, Gnana Ravi, et al.
Drug Development Research|June 18, 2022
A new exploration toward adamantane derivatives as potential anti-MDR agents: Design, synthesis, antimicrobial, and radiosterilization activity as potential topoisomerase IV and DNA gyrase inhibitorsAhmed Ragab, Moustafa S Abusaif, Dina S Aboul-Magd, et al.
Drug Development Research|January 9, 2023
PDE4 inhibitor Roflumilast modulates inflammation and lipid accumulation in PCOS mice to improve ovarian function and reduce DHEA-induced granulosa cell apoptosis in vitroXiaowei Ji, Yao Ye, Lin Wang, et al.
Drug Development Research|December 21, 2022
Therapeutic role of Artemether in the prevention of hepatic steatosis through miR-34a-5p/PPARα pathwayLi Chen, Shuang Yu, Shubing Hong, et al.
Pageof 138

Showing results (321-330 of 1,376) with videos related to

Sort By:
Pageof 138
Drug Development Research|January 21, 2020
Development and characterization of oxaceprol-loaded poly-lactide-co-glycolide nanoparticles for the treatment of osteoarthritisEmine Alarçin, Çağlar Demirbağ, Seher Karsli-Ceppioglu, et al.
Drug Development Research|March 29, 2020
Oridonin ameliorates carbon tetrachloride-induced liver fibrosis in mice through inhibition of the NLRP3 inflammasomeDong Liu, Hailong Qin, Bixian Yang, et al.
Drug Development Research|September 15, 2020
Osteoarthritis: Prognosis and emerging therapeutic approach for disease managementAmresh Kumar, Partha Palit, Sabu Thomas, et al.
Drug Development Research|July 14, 2021
Targeting TRAF3IP2 alleviates high glucose-induced cardiomyocyte inflammation and apoptosisJing Wei, Tao Yan, Yuanhong Liang
Drug Development Research|October 3, 2020
Evaluation of hyaluronic acid nanoparticle embedded chitosan-gelatin hydrogels for antibiotic releaseBengi Özkahraman, Emel Tamahkar, Neslihan İdil, et al.
Drug Development Research|December 5, 2019
New 3-unsubstituted isoxazolones as potent human neutrophil elastase inhibitors: Synthesis and molecular dynamic simulationMaria Paola Giovannoni, Letizia Crocetti, Niccolò Cantini, et al.
Drug Development Research|July 8, 2022
Engineering of A<sub>3</sub> Adenosine and P2Y Nucleotide Receptors and Their LigandsKenneth A Jacobson, Hak Sung Kim, Gnana Ravi, et al.
Drug Development Research|June 18, 2022
A new exploration toward adamantane derivatives as potential anti-MDR agents: Design, synthesis, antimicrobial, and radiosterilization activity as potential topoisomerase IV and DNA gyrase inhibitorsAhmed Ragab, Moustafa S Abusaif, Dina S Aboul-Magd, et al.
Drug Development Research|January 9, 2023
PDE4 inhibitor Roflumilast modulates inflammation and lipid accumulation in PCOS mice to improve ovarian function and reduce DHEA-induced granulosa cell apoptosis in vitroXiaowei Ji, Yao Ye, Lin Wang, et al.
Drug Development Research|December 21, 2022
Therapeutic role of Artemether in the prevention of hepatic steatosis through miR-34a-5p/PPARα pathwayLi Chen, Shuang Yu, Shubing Hong, et al.
Pageof 138